Avicanna (TSE:AVCN) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Avicanna Inc., a leader in cannabinoid-based biopharmaceuticals, successfully elected its management’s nominees as company directors and reaffirmed its auditor appointment during the Annual General Meeting. The company continues to progress in the medical cannabis industry with an expanding portfolio, including the RHO Phyto formulary and the MyMedi.ca care platform.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
